For Quick Alerts
For Daily Alerts

Sun Pharma tanks 4% on Taro's disappointing Q4 numbers

By Religare

Shares of Sun Pharma fell as much as 4 per cent in the morning trade on Bombay Stock Exchange (BSE) after its Israeli subsidiary Taro reported fall in operating margins for the fourth quarter ended March 2013.

Taro's operating profit margin fell by 7.4 per cent to 38.2 per cent in Jan-Mar quarter as against 45.6 per cent in a year ago period.

The net profits of Taro were up 4.2 per cent year-on-year at USD 49.2 million from USD 47.2 million. Net sales increased 13.8 per cent YoY to USD 165.1 million from USD 145.1 million.


At 12:00 hours, shares of Sun Pharma were trading at Rs 981.30 a piece, down 2.5 per cent from previous close on BSE.

Story first published: Friday, May 24, 2013, 23:38 [IST]
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'


We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more